Abstract

SESSION TITLE: Fellows Obstructive Lung Disease Posters SESSION TYPE: Fellow Case Report Posters PRESENTED ON: October 18-21, 2020 INTRODUCTION: Emphysema affects more than 4 million cases diagnosed in the US. Recently, bronchial valves were approved for selected patients with complete lobar fissure and severe hyperinflation. Unfortunately, most patients have collateral ventilation (CV) and thus are not candidates for bronchoscopic lung volume reduction alone. Combined minimally invasive thoracoscopic intervention to complete lung fissure along with bronchial valves (BVs) to achieve lung volume reduction is an appealing treatment for the majority of patients with CV. Our group has recently described the use of this combined procedure in animal models, but this is the first description in clinical practice. CASE PRESENTATION: A 58-year-old woman with severe heterogeneous emphysema and hyperinflation underwent endobronchial bronchial valves placement without significant improvement in her symptoms or pulmonary function tests at her 6 months follow-up visit. Following a multidisciplinary discussion with thoracic surgery, the patient underwent major fissure completion via VATS. The patient tolerated the procedure well and was discharged from the hospital on postoperative day 3. At 1-month follow up, patient-reported progressive improvement in her dyspnea. Her chest radiography showed atelectasis of the target lobe. Her lung function test showed an improvement of 0.1L (4%) in her FEV1, a decrease of 0.5L (27%) in her RV, and an increase of 1.4mL/min/mmHg (18%) in her DLCO. Another 59-year-old woman with severe homogeneous emphysema with hyperinflation. She underwent bronchial valve placement without significant improvement in her symptoms or pulmonary function tests at 12 months follow up visit. Following a multidisciplinary discussion with thoracic surgery, the patient underwent major fissure completion via VATS along with the removal of abundant pleural adhesions. She had an air leak for 3 days that resolved and was discharged home at postoperative day 4. At one month follow up, the patient had no improvement in her dyspnea. Her chest radiography showed hyperinflation without improvement in the lung function test. DISCUSSION: As emphysema remains an irreversible disease, treatment goals are primarily aimed to slow and stabilize disease progression, relieve symptoms, and improve quality of life. The most important factor that may prevent the development of desired lung volume reduction following bronchial valve treatment is CV. We present the first 2 cases in which a thoracoscopic approach was used to complete the interlobar fissures to address CV. The refinement of the technique along with appropriate patient selection is still under progress. CONCLUSIONS: Lobar fissure completion along with bronchial valves is a promising management alternative for patients with CV. Reference #1: Majid A, Kheir F, Alape D, Chee A, Parikh M, DeVore L, et al. Combined Thoracoscopic Surgical Stapling and Endobronchial Valve Placement For Lung Volume Reduction With Incomplete Lobar Fissures: An Experimental Pilot Animal Study. J Bronchol Interv Pulmonol. 2019 Aug;1. Reference #2: Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of COPD 2020. Reference #3: Koster D, Slebos D-J. The fissure: interlobar collateral ventilation and implications for endoscopic therapy in emphysema. Int J Chron Obstruct Pulmon Dis. 2016 Apr;765. DISCLOSURES: No relevant relationships by Sidhu Gangadharan, source=Web Response No relevant relationships by Fayez Kheir, source=Web Response Consultant relationship with Boston Scientific Please note: $1001 - $5000 by Adnan Majid, source=Web Response, value=Consulting fee Consultant relationship with olympus Please note: $5001 - $20000 by Adnan Majid, source=Web Response, value=Consulting fee Consultant relationship with pinacle biologics Please note: $1001 - $5000 by Adnan Majid, source=Web Response, value=Consulting fee Consultant relationship with cook medical Please note: $1001 - $5000 by Adnan Majid, source=Web Response, value=Consulting fee No relevant relationships by Daniel Ospina-Delgado, source=Web Response

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call